FeesSafety
Pluang+

TJX reports 4% sales growth, plans 2,100+ new stores, and resolves operational issues at Marmaxx.

Company Fundamentals
20 Nov 2026, 01:35 WIB
The Motley Fool
View Source
Bullish
TJX reports 4% sales growth, plans 2,100+ new stores, and resolves operational issues at Marmaxx.

TJX announced a 4% increase in comparable store sales for Q3 fiscal 2027, driven by strong off-price retail demand. The company expects to resolve operational challenges at its Marmaxx division by year-end, which is key to U.S. retail performance. TJX plans to expand its store count to 7,500, adding over 2,100 new locations, leveraging its global vendor network and flexible store formats. Management remains focused on balancing growth with capital returns and managing freight cost inflation.

TJX's recent business update provides context for readers interested in retail and consumer cyclical stocks. For readers following this sector, here is Pluang's market snapshot as of Nov 20, 2026 06:11 WIB: Of 134 priced Consumer Cyclical-sector US stocks tradable on Pluang, 9 rose and 124 fell today. Notable movers include PDD at USD 85.06 with a 1-day change of +9.83%, MINISO Group Holding Ltd at USD 10.56 down 9.74%, and Plby Group Inc at USD 1.17 down 9.69%.

More News

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

S&P 500's four-week drop after record high signals potential long-term gains, not a bear market.

The S&P 500 recently experienced a four-week losing streak following a record high, dropping about 8% from its peak. Historically, such declines have often been healthy pullbacks rather than signs of a bear market, with the index showing gains six an...

Market News
Bullish
1 hour ago
Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute's revenue rises but profit falls, shares drop nearly 9%.

Universal Technical Institute (UTI) reported a 6% increase in fourth-quarter revenue to $235.9 million, driven by a rise in full-time students. However, net income fell nearly 4% to just over $18 million, missing analyst earnings per share estimates....

Company Fundamentals
Bearish
1 hour ago
Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Michael Burry warns investors on risks in CoreWeave, Nebius, Nvidia, and chip stocks amid falling prices.

Investor Michael Burry highlighted risks in CoreWeave, Nebius, Nvidia, and semiconductor stocks, noting significant price drops due to rising borrowing costs and potential long-term challenges for Nvidia's competitive edge. CoreWeave and Nebius have ...

Market News
Bearish
1 hour ago
AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD's AI data center revenue nearly doubles, positioning it to challenge Nvidia's dominance.

AMD is gaining ground on Nvidia in the AI chip market, with its data center revenue nearly doubling year over year in Q3 and overall revenue up 45%. Nvidia faces leadership uncertainty after former CEO Jensen Huang's departure, creating an opportunit...

Market News
Bullish
1 hour ago
Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's new prostate cancer drug shows 75% response in early trials, boosting its strong pipeline.

Johnson & Johnson's investigational drug JNJ-6143, acquired through a $3.05 billion purchase of Halda Therapeutics, demonstrated a 75% overall response rate in a Phase 1 trial for metastatic castration-resistant prostate cancer. This promising early ...

Market News
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App